| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 02/24/2011 | US20110046200 Use of antisense oligonucleotides to effect translation modulation |
| 02/24/2011 | US20110046136 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associcated therewith |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110046057 Uses of cerberus and derivatives thereof |
| 02/24/2011 | DE102009037551A1 Cyclosporinderivate Cyclosporin derivatives |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2286810A1 Pharmaceutical composition for treatment of fibromyalgia |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | EP1227805B2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/23/2011 | CN101980726A Methods and means for treating DNA repeat instability associated genetic disorders |
| 02/23/2011 | CN101979087A Health liquor and preparation method thereof |
| 02/23/2011 | CN101978978A Solution with effect of repairing exercise-induced skeletal muscle microdamage |
| 02/23/2011 | CN101978958A Nutraceutical composition for the treatment of muscle wasting |
| 02/22/2011 | US7892531 Human serum albumin(HSA); solubilized in low-ionic-strength buffer with specified ph; glycine, aspartic acid, sodium succinate, trehalose; binds with receptors |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2474823C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
| 02/22/2011 | CA2328438C Heterocyclically substituted amides, their production and their use |
| 02/17/2011 | WO2011019348A1 CREATINE β-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE |
| 02/17/2011 | WO2011018588A2 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018587A2 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | US20110039877 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis |
| 02/17/2011 | US20110039855 Tetrahydrocyclopenta[b]indole Androgen Receptor Modulators |
| 02/17/2011 | US20110039810 Use of 25-hydroxy-vitamin d3 to affect human muscle physiology |
| 02/17/2011 | US20110038913 Polymeric endoprostheses with modified erosion rates and methods of manufacture |
| 02/17/2011 | CA2771056A1 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2771055A1 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/16/2011 | EP2284264A1 Induction of exon skipping in eukaryotic cells |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2284160A1 Pyrimidine derivative having cell-protecting activity and use thereof |
| 02/16/2011 | EP2283897A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283896A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283865A1 Method of increasing testosterone and related steroid concentrations in women |
| 02/16/2011 | EP2283849A1 Preparation of type a2 botulinum neurotoxin |
| 02/16/2011 | EP2282765A1 Thrombin derived peptides for smooth muscle relaxation |
| 02/16/2011 | EP1766010B1 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 02/16/2011 | CN101974487A Method for preparing neural stem cells with highest migration efficiency and application thereof |
| 02/16/2011 | CN101974485A Method for preparing mesenchymal stem cells with optimum transfer ability and application thereof |
| 02/16/2011 | CN101972413A Traditional Chinese medicine for treating facial paralysis |
| 02/16/2011 | CN101972339A Medicament for treating lumbar muscle strain |
| 02/16/2011 | CN101972240A Modafinil Composition |
| 02/16/2011 | CN101596223B Method for enriching ginkgetin compound |
| 02/16/2011 | CN101337109B Vehicle-mounted multifunctional physiotherapy equipment |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887795 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 02/15/2011 | CA2615271C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 02/15/2011 | CA2480872C Amino acids with affinity for the .alpha.-2-.delta.-protein |
| 02/15/2011 | CA2453254C Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia |
| 02/15/2011 | CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone |
| 02/10/2011 | WO2011016814A1 5α-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR |
| 02/10/2011 | WO2011016459A1 Thienooxazepine derivative |
| 02/10/2011 | US20110034566 Long term drug delivery devices with polyurethane based polymers and their manufacture |
| 02/10/2011 | US20110034527 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 02/10/2011 | US20110034421 Creatine oral supplementation using creatine hydrochloride salt |
| 02/10/2011 | US20110034372 Truncated activin type ii receptor and methods of use |
| 02/10/2011 | US20110033480 Methods and compositions involving nucleotide repeat disorders |
| 02/10/2011 | US20110033431 Type a2 botulinum toxin preparation |
| 02/10/2011 | US20110033428 Method for isolating smooth muscle stem cells |
| 02/10/2011 | US20110033412 Compositions and methods for treating and preventing skeletal muscle deficiencies |
| 02/09/2011 | EP2281828A2 Compositions comprising modified erythropoietin |
| 02/09/2011 | EP2281588A1 Semi-synthetic platelet gel and method for the preparation thereof |
| 02/09/2011 | EP2281568A2 Uses of soluble CTLA4 mutant molecules |
| 02/09/2011 | EP2280695A1 Hydroxytyrosol benefits mitochondria |
| 02/09/2011 | CN1961859B Novel formulation of Tizanidine and derivative thereof and preparation method thereof |
| 02/09/2011 | CN101970458A Novel gamma-secretase inhibitor |
| 02/09/2011 | CN101969979A Apoaequorin-containing compositions and methods of using same |
| 02/09/2011 | CN101967150A Spiroheterocyclic compounds and their uses as therapeutic agents |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/09/2011 | CN101272793B Sphingomyelin-containing medicine, food and drink or fodder |
| 02/08/2011 | US7884092 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/08/2011 | US7884072 produce more stem cells in vivo or in vitro by culture, for transplantation into patient; increase neurogenesis or new olfactory neuron numbers; stroke, neurodegenerative disease of Alzheimer's disease, multiple sclerosis, Huntington's disease, amyotrophic lateral sclerosis, and Parkinson's disease |
| 02/08/2011 | US7883881 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883706 Methods for using Streptococcus pyogenes polypeptides |
| 02/08/2011 | CA2494300C Growth hormone releasing peptides |
| 02/08/2011 | CA2439117C Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide |
| 02/03/2011 | WO2011014084A1 Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia |
| 02/03/2011 | WO2011013785A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | WO2011013699A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013646A1 Pharmaceutical product for prevention and treatment of amyotrophic lateral sclerosis |
| 02/03/2011 | WO2011013470A1 Autoantibody production inhibitor |
| 02/03/2011 | US20110028567 Smooth muscle contraction inhibitors |
| 02/03/2011 | US20110028542 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof |
| 02/03/2011 | US20110028392 Methods for use of branched amino acids |
| 02/03/2011 | US20110027373 Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathy |
| 02/03/2011 | CA2769181A1 Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia |
| 02/03/2011 | CA2767899A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/02/2011 | EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors |
| 02/02/2011 | EP2279742A2 Combinations for the treatment of immunoinflammatory disorders |
| 02/02/2011 | EP2278978A2 Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 02/02/2011 | EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 02/02/2011 | CN101961452A Method for preparing neck and waist rehabilitation medicinal plaster for treating osteoproliferation |
| 02/02/2011 | CN101961418A Double-controlled release, high-dosage and low-irritation capsaicin compound transdermal patch |
| 02/01/2011 | US7879966 pH-sensitive polymer |
| 02/01/2011 | US7879865 central nervous system disorders; brain cancer; oral administration |
| 02/01/2011 | US7879359 Compositions for preparing external carbon dioxide agents |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |